Immunity against fungal infections
Immunity against fungal infections
批准号:
10210883
负责人:
Somashekarappa Gowda Nanjappa
金额:
$46.61万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-01-15 至 2025-12-31
关键词:
AcheAdjuvantAdoptedAdoptive TransferAntifungal AgentsAntigen-Presenting CellsApoptosisBacterial InfectionsBlastomycesBone MarrowCD4 Positive T LymphocytesCD43 moleculeCD8-Positive T-LymphocytesCRISPR/Cas technologyCellsChimera organismCoupledCross PresentationCryptococcusDendritic CellsDendritic cell activationDevelopmentDiagnosisDifferentiation AntigensE-SelectinElementsFungal VaccinesGenesGenetic CrossesGoalsGranulocyte-Macrophage Colony-Stimulating FactorHistoplasmaHomeostasisImmuneImmunityImmunocompromised HostIndividualInterferon Type IIInterleukin-17Interleukin-2Knockout MiceLungLymphopeniaMarker VaccinesMediatingMemoryMonoclonal AntibodiesMorbidity - disease rateMusMutant Strains MiceMycosesNaturePPBP genePathologyPneumocystisPopulationPopulations at RiskPreventive measureReporterResistanceRiskRoleSeminalSignal TransductionSubunit VaccinesSurfaceSurface AntigensT cell responseT memory cellT-LymphocyteTC1 CellTNF geneTechniquesToxic effectVaccinationVaccinesVirus DiseasesWorkbasecongeniccytokinedesignefficacy testingexperimental studyfungal pneumoniafungusimmunopathologyin vivointerleukin-22metabolic fitnessmortalitymouse modelmutantnovelnovel vaccinesphenotypic biomarkerrecruitresponsevaccine accessvaccine efficacyvaccine responsevaccinology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Despite the global rise in fungal infections,
including those by endemic sp
., there is no licensed fungal vaccine
available. This is mainly due to poor understanding of mechanisms of vaccine immunity, and lack of
a functional
phenotypic marker associated with
vaccine efficacy. Opportunistic fungal infections, including those caused by
dimorphic fungi, Histoplasma, Coccidiodes and Blastomyces, are rising at an alarming rate in such at-risk
individuals. A major limitation in the development of tailored fungal vaccines for the at-risk population is poor
understanding of
requisite elements of CD8+ T cell responses to mediate vaccine-immunity.
Recent advances in
the understanding of immune correlates against fungal infections has helped in advancing vaccinology in parallel.
T-cell derived IL-17A, IFNγ, GM-CSF, IL-22, and TNFα are primarily involved in protection against fungi.
Identification of potential targets on host cells can provide novel efficacious vaccine platforms, including for
immunocompromised. We have established a mouse model of CD4+ T cell lymphopenia, where CD8+ T cells
can be stimulated to produce protective cytokines IL-17A (Tc17) and IFNγ (Tc1) to execute a sterilizing immunity
against lethal pulmonary fungal infection. We have shown that vaccine-elicited antifungal CD8+ T cells persisted
as long-term functional memory. In this proposal, we present seminal findings: 1. GM-CSF+ Tc17 cells bolster
vaccine-immunity without pathology; 2. Anti-fungal CD8+ T cells preferentially express O-glycosylated
Sialophorin; and 3. Sialophorin is required for differentiation and expansion of CD8+ T cells. Therefore, our
central hypotheses are that (1) Sialophorin acts as a co-stimulator for CD8+ T cell responses, (2) retention of
Sialophorin is essential for memory CD8+ T-cell homeostasis and recall responses, (3) Sialophorin signaling
potentiates cross-presentation to augment CD8+ T cell responses. Our specific aims are to: 1. Determine and
dissect the role of Sialophorin for CD8+ T-cell fungal vaccine responses. We will decipher and delineate the cell-
intrinsic role of Sialophorin for vaccine-induced Tc17 and Tc1 cell responses using adoptive transfer and bone-
marrow chimera experiments, and using TCRα KO, congenic and crosses of Sialophorin KO mice. 2. Elucidate
the role of Sialophorin for memory T cell homeostasis and recall responses during fungal pneumonia. We will
define the role of Sialophorin for vaccine-induced memory CD8+ T-cell homeostasis, recall responses, and
vaccine-immunity. We will use bone marrow chimera, adoptive transfers, CRISPR-Cas9 gene-editing, in vivo
stimulation, and E-selectin blocking to delineate the role of Sialophorin on memory CD8+ T-cell responses. 3.
Dissect the role of Sialophorin on dendritic cells for CD8+ T-cell fungal vaccine responses.
We will identify the
role of CD43 on antigen-presenting cells for activation of CD8+ T cells following vaccination
. Our findings will
uncover the functional role of Sialophorin for fungal CD8+ T-cell responses and immunity to guide in the design
of novel vaccine platforms and test the efficacy of vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunity against fungal infections
-
批准号:10535473
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2021
-
负责人:Somashekarappa Gowda Nanjappa
-
依托单位:
Immunity against fungal infections
-
批准号:10330033
-
项目类别:
-
资助金额:$45.59万
-
财政年份:2021
-
负责人:Somashekarappa Gowda Nanjappa
-
依托单位:
Role of GM-CSF+IL-17+ CD8+ T Cells in Respiratory Fungal Immunity
-
批准号:9234455
-
项目类别:
-
资助金额:$8.46万
-
财政年份:2016
-
负责人:Somashekarappa Gowda Nanjappa
-
依托单位:
Role of GM-CSF+IL-17+ CD8+ T Cells in Respiratory Fungal Immunity
-
批准号:9112127
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2016
-
负责人:Somashekarappa Gowda Nanjappa
-
依托单位:
海外基金